Skip to content

Screening and intervention program for cardiovascular disease high-risk people (coronary heart disease with diabetes) in Hubei Province

Effect of strict risk factor control on cardiovascular events in patients with coronary heart disease and diabetes in Hubei Province

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200062798
Enrollment
Unknown
Registered
2022-08-19
Start date
2022-08-19
Completion date
Unknown
Last updated
2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary heart disease complicated with diabetes

Interventions

Protocol treatment group:Strictly intervene blood glucose, blood pressure and blood lipids
Conventional treatment group:Treatment and management according to the guidelines

Sponsors

Union Hospital, Tongji Medical College of Huazhong University of science and technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. 40-75 years old, male or female; 2. Patients with coronary heart disease complicated with type 2 diabetes (confirmed by angiography); 3. Low density lipoprotein cholesterol >1.8mmol/l; 4. Signed written informed consent.

Exclusion criteria

Exclusion criteria: (1) Received coronary stent treatment in recent one year; (2) Pregnant or lactating women; (3) Decompensated stage of chronic systolic heart failure (NYHA cardiac function rating >= 3), Patients with severe cardiovascular complications such as septic shock; (4) Stroke patients in recent 1 year; (5) Patients with severe gastrointestinal diseases and liver and kidney failure; (6) Cancer patients or patients who have received radiotherapy or chemotherapy within five years; (7) Suffering from infectious diseases such as AIDS and tuberculosis; (8) Hospitalized or suffering from other serious diseases requiring immediate hospitalization; (9) Bad addicts: drug users or alcoholics (men consume alcohol >80 g / day,Women >40 g / day; (10) Disturbance of consciousness, inability to communicate normally or any mental illness; You can't take care of yourself or walk in life and those who are inconvenient to move; (11) Life expectancy <12 months; (12) Individuals with abnormal laboratory tests and clinical manifestations who are judged by the researcher to be unsuitable for participation; (13) Unwilling to participate in the trial, unwilling to change the current drug treatment plan.

Design outcomes

Primary

MeasureTime frame
Primary end point event;

Secondary

MeasureTime frame
Electrocardiograph;FBG(fasting blood-glucose);Glycated hemoglobin;Simple oral glucose tolerance test(OGTT);Alanine transaminase(ALT);Aspartate aminotransferase(AST);Blood Urea Nitrogen(BUN);Creatinine;Blood routine examination;Routine urine test;Fundus photographic examination;HCY(homocysteine);Total cholesterol;Triglyceride;High density lipoprotein cholesterol(HDL-C);Low density lipoprotein cholesterol(LDL-C);Height;Weight;Waist circumference;Hip circumference;Blood pressure;Pulse;

Countries

China

Contacts

Public ContactHuang Kai / Huo Yong

Union Hospital, Tongji Medical College of Huazhong University of science and technology / Peking University First Hospital

huangkai1@hust.edu.cn+86 13986102602/13901333060

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026